Hypertension,Essential Clinical Trial
Official title:
An Observational Study to Evaluate the Efficacy and Safety of Amosartan Plus Tablet in Uncontrolled Essential Hypertension Patients
This study was to evaluate the therapeutic effect and safety of Amosartan Plus tablet administration in uncontrolled essential hypertension patients. During the routine medical visit, Amosartan Plus tablets were administered to patients in need of blood pressure control according to the investigator's judgment. In this study, effectiveness and safety information of treatment of Amosartan Plus tablets was followed for 6 months (up to 12 months), and observation of the target patients was terminated after collecting relevant data. As this study was a non-interventional observational study, all patients received prescriptions according to the routine treatment procedure, and there were no visits or procedures required according to the observational study protocol.
This study was a multi-center, prospective, non-interventional, observational study of factors affecting blood pressure after treatment with Amosartan Plus tablet in uncontrolled essential hypertension patients. Data was collected from patients receiving routine treatment at hospitals in South Korea. Each patient visited the institution according to the protocol that designed the follow-up visits for six months to examine the effectiveness and safety of Amosartan Plus tablet. This study approved by the institutions' IRBs and was conducted in compliance with clinical research ethics regulations. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05546931 -
Mobile Health Program for Rural Hypertension
|
N/A | |
Completed |
NCT05086549 -
An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
|
||
Recruiting |
NCT05086523 -
Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03503773 -
The TARGET BP OFF-MED Trial
|
Phase 2 | |
Not yet recruiting |
NCT04082091 -
Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
|
||
Recruiting |
NCT06019598 -
Licorice and Home Blood Pressure, Additional Study
|
N/A | |
Completed |
NCT04495231 -
Sympathetic Activity and Cardiometabolic Complications
|
||
Completed |
NCT04119999 -
A Cardiosleep Research Program on Obstructive Sleep Apnea, Blood Pressure Control and Maladaptive Myocardial Remodeling
|
N/A | |
Recruiting |
NCT04505618 -
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
|
N/A | |
Recruiting |
NCT04863508 -
Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.
|
||
Completed |
NCT05185297 -
Recreational Futsal for Controlled Hypertension
|
N/A | |
Completed |
NCT03855605 -
Diagnosis of Hypertension by Home Blood Pressure Monitoring
|
||
Completed |
NCT03901183 -
Plant-based Nutrition for Patients With Cardiovascular Risk Factors
|
N/A | |
Recruiting |
NCT06348576 -
Phase III Study to Evaluate the Efficacy and Safety of AD-209
|
Phase 3 | |
Recruiting |
NCT03206814 -
Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
|
N/A | |
Recruiting |
NCT06343246 -
Functional Inspiratory Muscle Training in Patients Diagnosed With Hypertension
|
N/A | |
Completed |
NCT06359873 -
Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension
|
||
Recruiting |
NCT04565548 -
Hypertension Treatment Adherence Improving Trial
|
N/A | |
Recruiting |
NCT06205628 -
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
|
Phase 1 | |
Recruiting |
NCT04613193 -
Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis
|
N/A |